Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Most type 1 diabetes patients maintain acceptable glycemic control through subcutaneous insulin that is either injected multiple times a day or continuously infused through an external insulin pump. Despite intensive subcutaneous insulin therapy, a relatively small group of type 1 diabetics fails to reach adequate glycemic control, has frequent hypoglycemic episodes, or develops insulin resistance.
Recently, researchers in the Netherlands studied the long-term use of continuous intraperitoneal insulin infusion (CIPII) for type 1 diabetics with histories of poor glycemic control, defined as glycated hemoglobin (HbA1c) ≥7.5% and/or 5 or more incidents of hypoglycemia per week. Their research originated in 2006 as a randomized crossover study to investigate the effects of CIPII on the risk of hypoglycemia compared to intensive subcutaneous insulin treatment.
http://www.hcplive.com/articles/Con...es-Long-term-Effectiveness-in-Type-1-Diabetes
Recently, researchers in the Netherlands studied the long-term use of continuous intraperitoneal insulin infusion (CIPII) for type 1 diabetics with histories of poor glycemic control, defined as glycated hemoglobin (HbA1c) ≥7.5% and/or 5 or more incidents of hypoglycemia per week. Their research originated in 2006 as a randomized crossover study to investigate the effects of CIPII on the risk of hypoglycemia compared to intensive subcutaneous insulin treatment.
http://www.hcplive.com/articles/Con...es-Long-term-Effectiveness-in-Type-1-Diabetes